Sangui BioTech International Inc - Company Profile
Powered by
All the data and insights you need on Sangui BioTech International Inc in one report.
- Save hours of research time and resources with
our up-to-date Sangui BioTech International Inc Strategy Report
- Understand Sangui BioTech International Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Sangui Biotech International Inc (Sangui Biotech), formerly Citadel Investment System, Inc, is a pharmaceutical company that develops novel and proprietary pharmaceuticals, medical products and cosmetics. Sangui Biotech's product portfolio includes artificial oxygen carriers, nanoformulations for the regeneration of skin, wound pads and wound spray. It also markets wound dressing products to support wound healing process in the name of chitoskin. The company develops oxygen carriers that can transport oxygen in acute and chronic conditions such as arterial blockage or anemia following injury, surgery, or other causes in humans. Sangui Biotech markets the products in European countries, and Mexico through its subsidiary, and network of distribution partners. Sangui Biotech is headquartered in Hamburg, Germany
Products and Services
Products | Brands |
---|---|
Artificial Oxygen Carriers | Granulox |
Nano Formulations. | |
Wound Pads | |
XYZ | |
XYZ | |
XYZ |
Competitor Comparison
Key Parameters | Sangui BioTech International Inc | Johnson & Johnson | Bristol-Myers Squibb Co | Sanara MedTech Inc | Derma Sciences Inc |
---|---|---|---|---|---|
Headquarters | Germany | United States of America | United States of America | United States of America | United States of America |
City | Hamburg | New Brunswick | Princeton | Fort Worth | Princeton |
State/Province | Baden-Wurttemberg | New Jersey | New Jersey | Texas | New Jersey |
No. of Employees | 1 | 131,900 | 34,100 | 101 | - |
Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Thomas Striepe | Chief Executive Officer; Director | Executive Board | 2005 | - |
Hubertus Schmelz | Director | Non Executive Board | 2008 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer